Valuation: DBV Technologies

Market Cap 726M 829M 674M 619M 1.17B 79.97B 1.18B 8.03B 3.14B 39.13B 3.11B 3.04B 135B P/E 2026 *
-5x
P/E 2027 * -17.2x
Enterprise Value 651M 743M 604M 555M 1.05B 71.66B 1.06B 7.2B 2.82B 35.07B 2.79B 2.73B 121B EV / Sales 2026 *
254x
EV / Sales 2027 * 10x
Free-Float
99.84%
Yield 2026 *
-
Yield 2027 * -
1 day-2.12%
1 week-13.10%
Current month-14.40%
1 month-13.22%
3 months-28.43%
6 months-36.03%
Current year-26.09%
1 week 2.4
Extreme 2.402
2.62
1 month 2.4
Extreme 2.402
2.86
Current year 2.4
Extreme 2.402
4.14
1 year 1.41
Extreme 1.412
4.75
3 years 0.44
Extreme 0.4355
4.75
5 years 0.44
Extreme 0.4355
10.42
10 years 0.44
Extreme 0.4355
84.99
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 62 21/06/2016
Director/Board Member 60 15/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%-13.10% - - 835M
+0.96%+3.12%+56.19%+15.47% 312B
+1.97%-2.28%+25.65%-11.82% 66.59B
-0.99%+2.64%+35.25%+81.44% 9.32B
-1.14%-1.83%+2.95%-4.87% 8.53B
-1.03%-1.79%-24.11%-10.07% 4.1B
+0.38%-9.58%-5.58%+22.13% 3.76B
+0.86%+1.01%-43.84%+10.01% 3.51B
-1.94%-1.66%+43.68%+53.35% 2.78B
-2.81%-6.33%+5.13%-9.94% 2.19B
Average -0.59%-0.87%+10.59%+16.19% 45.85B
Weighted average by Cap. +0.96%+3.06%+47.12%+12.02%

Financials

2026 *2027 *
Net sales 2.56M 2.92M 2.38M 2.18M 4.12M 282M 4.18M 28.32M 11.09M 138M 10.97M 10.74M 477M 70.24M 80.16M 65.2M 59.92M 113M 7.74B 115M 777M 304M 3.78B 301M 294M 13.08B
Net income -174M -199M -162M -149M -280M -19.17B -284M -1.93B -754M -9.38B -746M -730M -32.41B -116M -132M -108M -98.95M -186M -12.77B -189M -1.28B -502M -6.25B -497M -486M -21.59B
Net Debt -75.46M -86.12M -70.05M -64.37M -121M -8.31B -123M -835M -327M -4.07B -323M -316M -14.05B -22.7M -25.91M -21.07M -19.37M -36.49M -2.5B -37.03M -251M -98.26M -1.22B -97.26M -95.16M -4.23B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change
22/07/26 €2.402 -2.12%
21/07/26 €2.454 -0.81%
20/07/26 €2.474 -5.43%
17/07/26 €2.616 -0.91%
16/07/26 €2.640 -4.49%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.454EUR
Average target price
3.800EUR
Spread / Average Target
+54.85%

Quarterly revenue - Rate of surprise